Nutrimatch
What the evidence actually shows
Ginkgo biloba is one of the longest-studied herbal supplements for cognitive health, with a substantial trial base focused on slowing age-related cognitive decline and improving cerebral blood flow. The strongest current evidence supports modest reductions in cognitive decline in older adults — particularly those with mild cognitive impairment or early dementia. The clinical signal is small but consistent across multiple large trials.
The evidence is good for improvements in cerebral blood flow, modest gains in memory, processing accuracy, and attention in older adults, reduced intermittent claudication symptoms (walking distance in peripheral vascular disease), reductions in acute mountain sickness symptoms, modest reductions in LDL cholesterol, and reductions in tinnitus in some specific subgroups.
What ginkgo does poorly is reliably enhance cognition in healthy young adults. Despite extensive marketing as a brain booster for students and professionals, randomised trials in this population consistently show small or no effect. The supplements that work for acute cognitive performance in healthy people are not in the ginkgo family.
The reproducibility of trial results also depends heavily on the extract used. EGb 761 (the standardised extract used in most positive trials) is the form supported by the evidence base. Unstandardised ginkgo leaf or non-Egb formulations show much more variable results, which partly explains why some users report no effect.
How it works
Ginkgo biloba extract contains two main families of active compounds: ginkgo flavonol glycosides (about 24% of standardised extract) and terpene lactones (about 6%, including ginkgolides and bilobalide). Together these produce three primary effects relevant to cognition.
The first is improved cerebral blood flow through mild vasodilation and reduced platelet aggregation, increasing oxygen and glucose delivery to brain tissue. The second is antioxidant activity, particularly within neurons exposed to age-related oxidative stress. The third is modulation of neurotransmitter systems, including acetylcholine and dopamine pathways relevant to memory and attention.
These mechanisms explain why ginkgo is more reliably useful in older adults (whose cerebral perfusion is already compromised) than in healthy young people (whose brain blood flow is already optimal). The benefits emerge slowly with consistent use — most trials report measurable effects at 12–24 weeks.
Who benefits most — and who should be cautious
The clearest beneficiaries are older adults with mild cognitive impairment or early Alzheimer's disease (typically under medical guidance), people with intermittent claudication or peripheral vascular disease, those with tinnitus of vascular origin, and travellers experiencing acute mountain sickness.
The case is much weaker for healthy adults without identifiable cerebrovascular or cognitive concerns.
The main cautions are bleeding risk and interactions. Ginkgo has mild antiplatelet effects, which can compound the effect of anticoagulants (warfarin, aspirin, clopidogrel). Discontinue at least 7 days before scheduled surgery. People with seizure disorders should avoid ginkgo — there are scattered reports of seizure risk, particularly with seeds rather than leaf extract.
Common side effects include mild headache, gastrointestinal upset, and occasional palpitations. Allergic reactions to ginkgo seed pulp (raw ginkgo nuts) can be severe; standard leaf-extract supplements do not pose this risk.
How to take it
Form. Choose a standardised extract specifying EGb 761 or an equivalent (typically 24% flavonol glycosides and 6% terpene lactones). Generic ginkgo leaf powder is much less reliable.
Dose.
- Cognitive support in older adults: 120–240 mg/day of standardised extract, divided
- Intermittent claudication: 120–160 mg/day
- Tinnitus: 120–160 mg/day for a minimum 4-month trial
- Mountain sickness prevention: 100–120 mg twice daily starting 4–5 days before ascent
Timing. Splitting the dose (e.g., morning and afternoon) produces steadier blood levels than a single large dose.
Be patient. Cognitive effects emerge over 12–24 weeks. Acute use does not meaningfully change cognition.
Common misconceptions
Ginkgo boosts memory in healthy people. It does not, reliably. The evidence is concentrated in older adults with cognitive decline. Healthy younger people typically see no measurable benefit.
All ginkgo supplements are equivalent. They are not. EGb 761 and equivalently standardised extracts are what the trials use. Unstandardised products vary widely in active content.
Ginkgo can prevent or reverse dementia. It can modestly slow cognitive decline in mild cases — it does not prevent dementia or reverse established Alzheimer's disease.
It works quickly. It does not. People expecting acute cognitive enhancement are usually disappointed; trial benefits appear over months.
Higher doses produce stronger effects. Above 240 mg/day, additional benefit is small while side effect risk (particularly bleeding) increases.
FAQ
How long until I notice effects? 12–24 weeks for cognitive effects. Some people notice improvements in tinnitus or claudication earlier, around 8 weeks.
Can I take it with my heart or blood pressure medication? Possibly — but consult a prescriber first, particularly if you take anticoagulants or antiplatelet drugs.
Will it work for my age-related memory complaints? The strongest effect is in adults with diagnosed mild cognitive impairment. For ordinary age-related memory changes without significant decline, effects are smaller and less reliable.
Does it interact with medications? With anticoagulants, antiplatelet drugs, NSAIDs, SSRIs, and some seizure medications. Mention regular ginkgo use to your prescriber, particularly before surgery.
Is it safe in pregnancy? No. Ginkgo is generally not recommended in pregnancy due to limited safety data and potential bleeding concerns at term.
Evidence grades and benefit rankings on this page are sourced from Examine.com, an independent research database with no industry funding.